BIOMAT Database Logo BIOMAT Database Logo

Estrogen receptor antagonist fulvestrant (ICI 182,780) inhibits the anti-inflammatory effect of glucocorticoids. 2007

Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
Department of Clinical and Experimental Medicine, School of Medicine, University of Messina, Messina, Italy. salvator@unime.it

The glucocorticoid receptor (GR) and estrogen receptor (ER) play important roles in both physiological and pathological conditions involving cell growth and differentiation, lipolysis, control of glucose metabolism, immunity, and inflammation. In fact, recent studies suggest that 17beta-estradiol, like glucocorticoids, may also have anti-inflammatory properties, even if the molecular mechanisms responsible for these activities have not yet been completely clarified. The present study was designed to gain a better understanding of the possible cross-talk between GR and ER in a model of lung inflammation (carrageenan-induced pleurisy). In particular, we have investigated whether fulvestrant (ICI 182,780), a selective ER-alpha antagonist, is able to attenuate the well known anti-inflammatory effect of dexamethasone (DEX), a synthetic glucocorticoid, in ovariectomized rats. We show that ICI 182,780, a selective ER-alpha antagonist, reverses the anti-inflammatory activity exhibited by DEX. Moreover, the coadministration of ICI 182,780 significantly inhibited the ability of DEX to reduce: 1) the degree of lung injury, 2) the rise in myeloperoxidase activity, 3) the increase of poly-(ADP-ribose) polymerase activity, tumor necrosis factor alpha, and interleukin-1beta levels, 4) inducible nitric-oxide synthase, 5) lipid peroxidation, 6) nitrotyrosine formation, 7) cyclooxygenase expression, and 8) the IkappaB-alpha degradation caused by carrageenan administration. In addition, quantitative PCR shows that DEX down-regulates GR and up-regulates glucocorticoid-induced leucine zipper levels, whereas ICI 182,780 does not counteract these effects. In conclusion, these results suggest that the in vivo anti-inflammatory property of DEX is also related to the ER-alpha.

UI MeSH Term Description Entries
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D000077267 Fulvestrant An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer. 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol,Faslodex,ICI 182,780,ICI 182780,ICI-182780,ZM 182780,ZM-182780,ICI182780,ZM182780
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha.
April 2006, The Journal of biological chemistry,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
June 2010, Breast cancer research and treatment,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
The specific estrogen receptor antagonist ICI 182,780 masculinizes development of the zebra finch syrinx.
April 2008, General and comparative endocrinology,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
ICI 182,780 (Fulvestrant)--the first oestrogen receptor down-regulator--current clinical data.
November 2001, British journal of cancer,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
The high-affinity estrogen receptor antagonist ICI 182,780 has no effect on bone growth in young male rats.
June 2000, Calcified tissue international,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats.
December 1993, Endocrinology,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780.
November 1993, International journal of cancer,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia.
September 1998, Endocrinology,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
Fulvestrant: an estrogen receptor antagonist that downregulates the estrogen receptor.
October 2003, Seminars in oncology,
Salvatore Cuzzocrea, and Stefano Bruscoli, and Concetta Crisafulli, and Emanuela Mazzon, and Massimiliano Agostini, and Carmelo Muià, and Emanuela Esposito, and Rosa Di Virgilio, and Rosaria Meli, and Elisabetta Vegeto, and Adriana Maggi, and Carlo Riccardi
Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
August 2004, Nuclear medicine and biology,
Copied contents to your clipboard!